Clinical Trial Update: Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation

View source ↗

Summary

This completed study from Karolinska Institutet assesses whether PSA-based screening influences mortality in men aged 75-79 using target trial emulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Karolinska Institutet | Conditions: Prostate Cancer, Prostate Cancer Screening | Status: COMPLETED